D. Lynne Smith

3.3k citations

76 papers · 2.4k indexed · h-index 25

Impact in

Oncology top 5%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in

Oncology 26
- Viral-associated cancers and disorders 10
- CAR-T cell therapy research 6
Genetics 7
- Chronic Lymphocytic Leukemia Research 7

Co-authors: Parkash S. Gill Rizwan Masood Tong Zheng Jie Cai Ross Wilkie David R. Hinton John McBeth Yathi M. Naidu
Journals: Blood (8 papers)International Journal of Cancer (2 papers)Molecular and Cellular Endocrinology (2 papers)Cancer Research (2 papers)Cancer Immunology Immunotherapy (2 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

D. Lynne Smith

71 papers receiving 2.3k citations

Peers

Countries citing papers authored by D. Lynne Smith

Since Specialization

Citations

This map shows the geographic impact of D. Lynne Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lynne Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lynne Smith more than expected).

Fields of papers citing papers by D. Lynne Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lynne Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lynne Smith. The network helps show where D. Lynne Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Lynne Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Lynne Smith Line = papers co-authored together D. Lynne Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma Leukemia & lymphoma ·颜学孔, Geoffrey Shouse, Lu Chen, D. Lynne Smith, Jessica H. Ford, Alex F. Herrera, Lihua E. Budde, Tanya Siddiqi, Avyakta Kallam, Tycel Phillips, Ramón Valentín-Gamazo Abril	2025	0
2	Phase 1 trial of durvalumab (anti–PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma Blood Advances ·Christiane Querfeld, Joycelynne Palmer, Jennifer Freymann, 隆一蘆田, Yate‐Ching Yuan, Д К Джаватов, Tikamporn Jitpasutham, Katrine Aagaard Lentz, D. Lynne Smith, Samantha N. Hammond, P. R. Moulinié, Joo Y. Song, Raju Pillai, P. POONKODI N. SENTHILKUMAR, Jasmine M. Zain	2025	3
3	Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti−PD-L1 in Cutaneous T-Cell Lymphoma Journal of Investigative Dermatology ·Jennifer Freymann, Xiwei Wu, Hanjun Qin, Yate‐Ching Yuan, Jasmine M. Zain, D. Lynne Smith, Oleg E. Akilov, Steven T. Rosen, Mingye Feng, Christiane Querfeld	2023	14
4	Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions Cancer Immunology Immunotherapy ·Zhenyuan Dong, Wesley A. Cheng, D. Lynne Smith, Brian Z. Huang, Tiantian Zhang, Wen-Chung Chang, Xiuli Wang, Stephen J. Forman, Larry W. Kwak, Hong Qin	2020	17
5	Reasons why osteoarthritis predicts mortality: path analysis within a Cox proportional hazards model RMD Open ·Ross Wilkie, S. Parmar, Milica Bucknall, D. Lynne Smith, Martin J. Thomas, Masahisa HIRONAKA, Gemma Mansell, George Peat	2019	22
6	Reasons why osteoarthritis predicts mortality: path analysis within a cox proportional hazards model Osteoarthritis and Cartilage ·S. Parmar, D. Lynne Smith, Ross Wilkie	2018	2
7	Targeting myeloid-derived suppressor cells for cancer immunotherapy Cancer Immunology Immunotherapy ·Yijun Liu, Guo‐Wei Wei, Wesley A. Cheng, Zhenyuan Dong, Han Sun, Takashi Koike, Soung-Chul Cha, D. Lynne Smith, Larry W. Kwak, Hong Qin	2018	91
8	Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo Clinical Cancer Research ·Hong Qin, Guo‐Wei Wei, Ippei Sakamaki, Zhenyuan Dong, Wesley A. Cheng, D. Lynne Smith, Feng Wen, Han Sun, Kunhwa Kim, Ricard Pedreira Font, Laura Bover, Sattva S. Neelapu, Larry W. Kwak	2017	24
9	The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro Molecular Pharmacology ·Mei-Chuan Chen, Bingsen Zhou, Keqiang Zhang, Yate‐Ching Yuan, Frank Un, Shuya Hu, Chih‐Ming Chou, Chun‐Han Chen, Jun Wu, Yan Wang, Xiyong Liu, D. Lynne Smith, Frank Hong, Zheng Liu, Charles Warden, Leila Su, Linda H. Malkas, Young‐Min Chung, Mickey C.‐T. Hu, Yun Yen	2015	23
10	A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance Cancer Research ·Bingsen Zhou, Leila Su, Shuya Hu, Weidong Hu, M.L. Richard Yip, Jun Wu, Shikha Gaur, D. Lynne Smith, Yate‐Ching Yuan, Timothy W. Synold, David Horne, Yun Yen	2013	65
11	Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion PLoS ONE ·Mohd W. Nasser, Zahida Qamri, Yadwinder S. Deol, D. Lynne Smith, Konstantin Shilo, Xianghong Zou, Ramesh K. Ganju	2011	73
12	Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Clinical Lymphoma & Myeloma ·Anil Tulpule, Byron M. Espina, Nancy E.J. Berman, K. J. Wall, D. Lynne Smith, Andy Sherrod, K. Reicher, Conway Gee, William D. Boswell, Bharat N. Nathwani, Lauri Welles, Alexandra M. Levine	2006	19
13	Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops International Journal of Cancer ·Rizwan Masood, Shary Josephin, Sutao Zhu, Guangbin Xia, Pierluigi Scalia, D. Lynne Smith, Parkash S. Gill	2003	113
14	Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor American Journal Of Pathology ·Rizwan Masood, Ethel Cesarman, D. Lynne Smith, Parkash S. Gill, Ornella Flore	2002	68
15	Paclitaxel Induces Apoptosis in AIDS‐Related Kaposi′s Sarcoma Cells Sarcoma ·Jie Cai, Tong Zheng, Rizwan Masood, D. Lynne Smith, David R. Hinton, Jaume 1846-1932 Collell i Bancells, Guofu Fang, Kapil N. Bhalla, Parkash S. Gill	2000	9
16	Regional microbiology of the cystic fibrosis lung: a post-mortem study in adults Journal of Infection ·D. Lynne Smith, E. Grace Smith, Tyrone L. Pitt, D E Stableforth	1998	15
17	Human renin 5′-flanking DMA to nucleotide -2750 DNA sequence ·D. Lynne Smith, Bruno Wüstenberg, Julie Lang, Xiao-Hui Guo, Curt D. Sigmund, Brian Morris	1995	4
18	Identification of Cyclic AMP Response Element in the Human Renin Gene Biochemical and Biophysical Research Communications ·D. Lynne Smith, Brian J. Morris, Minghan Xiang, R E Law, Kathy Shaw, Adisp	1994	18
19	Prorenin and gene activation Canadian Journal of Physiology and Pharmacology ·Brian J. Morris, D. Lynne Smith	1991	5
20	Orally active prostacyclin-mimetic RS-93427: therapeutic potential in vascular occlusive disease associated with atherosclerosis. PubMed ·Wilson David, D. Lynne Smith, Carmen Vigo, Arthur F. Kluge, Counde O-Yang, D Kertesz, Wu H	1987	5

About D. Lynne Smith

D. Lynne Smith is a scholar working on Oncology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Pharmacology, having authored 76 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), Angiogenesis and VEGF in Cancer (7 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers), Musculoskeletal pain and rehabilitation (5 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). The work is most often cited by research in Oncology (799 citations), Cancer Research (342 citations), Molecular Biology (1.0k citations), Pathology and Forensic Medicine (270 citations) and Pharmacology (236 citations). D. Lynne Smith has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Parkash S. Gill, Rizwan Masood, Tong Zheng, Jie Cai, Ross Wilkie, Jie Cai, David R. Hinton, John McBeth, Yathi M. Naidu and Guangbin Xia. Their work appears in journals such as Blood, International Journal of Cancer, Molecular and Cellular Endocrinology, Cancer Research and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact